Another example is the stabilization of the positively charged tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) which displays high anti-cancer potency but a very short blood half-life of less than 30 minutes. The gene discussed is TNF; the disease is cancer.